March 20, 2007 – Siemens recently announced it has acquired rights to sell the MammoTest breast biopsy system from Hologic, who will maintain royalty-free, non-exclusive rights to the product.
The system will reportedly be sold at a reduced price and offers package deals and promotional offers. Siemens is now taking orders for the system, which will be released for delivery during the last two weeks of March 2007.
May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual ...
May 10, 2024 
Decades since the advent of breast scanning technology, innovations in noninvasive diagnostic imaging provide new ...
May 03, 2024 
May 1, 2024 — Hologic, Inc., a global leader in women’s health, today announced that it signed a definitive agreement to ...
May 01, 2024 
May 1, 2024 — The American College of Radiology (ACR) has issued a statement on the newly released Final USPSTF Breast ...
May 01, 2024 
April 30, 2024 — The U.S. Preventive Services Task Force (Task Force) today published a final recommendation statement ...
April 30, 2024 
Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...
April 15, 2024 
April 2, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced ...
April 02, 2024 
March 20, 2024 — Interval breast cancer is one that appears between two reviews of a screening program. That is, it is ...
March 20, 2024 
March 15, 2024 — Screening-detected radial scars without atypia at core-needle biopsy (CNB) have a low upstaging rate to ...
March 15, 2024 
March 6, 2024 — There is a pressing need to explore and understand which social determinants of health (SDOH) and health ...
March 06, 2024